|
Dr. Corrigan joined Sepracor in 2003 as Executive Vice President of Research and Development. Prior to joining Sepracor, Dr. Corrigan joined the Upjohn Company in 1993, which became Pharmacia Corp. in 1996. At Pharmacia, Dr. Corrigan served as Group Vice President of Global Clinical Research and Experimental Medicine and in 1998, was promoted to Group Vice President, Global Clinical Research, with responsibility for clinical research, biostatistical/data management and global procurement for compounds in Phases I-IIIB.
Prior to joining the pharmaceutical industry with the Upjohn Company, Dr. Corrigan spent seven years in academic research at the University of North Carolina Medical School, focusing in psychoneuroendocrinology. During his tenure, Dr. Corrigan was a principal investigator for several novel antipsychotics and continues to maintain an appointment as Adjunct Clinical Professor of Psychiatry.
Dr. Corrigan has over twenty years of experience in treating psychiatric and central nervous system disorders and is board certified in psychiatry and neurology.
Dr. Corrigan earned his undergraduate and medical degrees from the University of Virginia and subsequently received specialty training in psychiatry at Cornell and Maine Medical Center.
Dr. Corrigan serves as a board member of Neuromed Technologies Inc. and has been elected as a Distinguished Fellow of the American Psychiatric Association (APA). | 